Literature DB >> 18785782

[In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates].

Adriana Sánchez1, Patricia Escandón, Elizabeth Castañeda.   

Abstract

Different phenotypic characteristics associated with virulence of the Cryptococcus neoformans species complex have shown an important role in their pathogenicity. In this study we have determined the role of phenotypically and genotypically factors of some virulence factors from clinical isolates in the two species of the complex; 35 C. neoformans and 19 Cryptococcus gattii. Growth at 37 degrees C, macroscopic and microscopic morphology, switching phenomenon, activity of 23 extracellular enzymes, variability of the colonies in agar with phloxin B; phospholipase B gene, and the mating type were determined by PCR; the molecular pattern was determined by URA5 RFLP. All isolates grew at 37 degrees C, the capsular size was greater in C. gattii (1.87 microm -/+1.47 microm) than in C. neoformans (0.83 microm -/+0.15 microm). Switching was observed mainly in isolates of C. gattii. All isolates expressed the enzyme urease, a lower activity of the proteases (Pz= 0.54), but a higher activity of the phospholipase (Pz=0.43) and phenoloxidase (Pz=0.003) was determined for C. gattii.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785782     DOI: 10.1016/s1130-1406(08)70034-2

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  6 in total

1.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

2.  Repression of Proteases and Hsp90 Chaperone Expression Induced by an Antiretroviral in Virulent Environmental Strains of Cryptococcus neoformans.

Authors:  Cleber Fernando Serafin; Ana Paula Paris; Claudete Rodrigues Paula; Rita Cássia Garcia Simão; Rinaldo Ferreira Gandra
Journal:  Microb Ecol       Date:  2016-12-02       Impact factor: 4.552

3.  Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.

Authors:  Leonardo Euripedes Andrade-Silva; Kennio Ferreira-Paim; Thatiana Bragine Ferreira; Anderson Vilas-Boas; Delio José Mora; Verônica Morais Manzato; Fernanda Machado Fonseca; Kelli Buosi; Juliana Andrade-Silva; Bruno da Silva Prudente; Natalia Evelyn Araujo; Helioswilton Sales-Campos; Marcus Vinicius da Silva; Virmondes Rodrigues Júnior; Wieland Meyer; Mario Léon Silva-Vergara
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

4.  Genotypic Diversity Is Independent of Pathogenicity in Colombian Strains of Cryptococcus neoformans and Cryptococcus gattii in Galleria mellonella.

Authors:  Norida Velez; Maira Alvarado; Claudia Marcela Parra-Giraldo; Zilpa Adriana Sánchez-Quitian; Patricia Escandón; Elizabeth Castañeda
Journal:  J Fungi (Basel)       Date:  2018-07-05

5.  Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections.

Authors:  Noura M Seleem; Hemat K Abd El Latif; Moataz A Shaldam; Amira El-Ganiny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-23       Impact factor: 3.267

6.  Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal Susceptibility.

Authors:  Lana Sarita de Souza Oliveira; Luciana Magalhães Pinto; Mariana Araújo Paulo de Medeiros; Dena L Toffaletti; Jennifer L Tenor; Tânia Fraga Barros; Rejane Pereira Neves; Reginaldo Gonçalves de Lima Neto; Eveline Pipolo Milan; Ana Carolina Barbosa Padovan; Walicyranison Plinio da Silva Rocha; John R Perfect; Guilherme Maranhão Chaves
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.